ARCHIVES

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Dana-Farber, Harvard And Affiliates Form Cancer Center.

February 4, 2000

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

Breast Cancer Strategic Plan Underway Following HHS Secretary’s Conference

January 7, 1994

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

DCE Board Approves Concept For studies Of Thorotrast Exposure

November 16, 1990